CATALYST PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2024.
  • Catalyst Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $55.9M, a 60.5% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $164M, a 130% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $164M, a 130% increase from 2023.
  • Catalyst Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $71.4M, a 14% decline from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $83.1M, a 110% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $164M $55.9M +$21.1M +60.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $143M $43.9M +$74.6M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $68.1M $40.8M +$3.03M +8.03% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 $65.1M $23.3M -$6.29M -21.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 $71.4M $34.8M +$9.37M +36.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-26
Q3 2023 $62M -$30.8M -$53.5M -235% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $116M $37.8M +$16.1M +74.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 $99.4M $29.6M +$16.3M +123% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 $83.1M $25.5M +$16.2M +174% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-26
Q3 2022 $66.9M $22.7M +$12.4M +120% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $54.5M $21.6M +$9.44M +77.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 $45.1M $13.2M +$5.58M +72.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 $39.5M $9.31M -$2.13M -18.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $41.6M $10.3M -$33M -76.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $74.6M $12.2M +$2.4M +24.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 $72.2M $7.66M -$2.76M -26.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 $75M $11.4M +$3.51M +44.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $71.5M $43.3M +$29.7M +218% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $41.8M $9.78M -$1.18M -10.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 $42.9M $10.4M +$11.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 $31.9M $7.93M +$22.4M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 $9.45M $13.6M +$21.5M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$12M $11M +$16.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$28.9M -$645K +$5.06M +88.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$34M -$14.5M -$9.11M -169% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$24.9M -$7.84M -$3.66M -87.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$21.2M -$5.97M -$2.09M -53.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$19.1M -$5.7M -$733K -14.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$18.4M -$5.39M -$1.22M -29.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$17.2M -$4.18M -$224K -5.66% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$17M -$3.88M +$689K +15.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$17.7M -$4.97M +$419K +7.78% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$18.1M -$4.16M +$1.65M +28.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$19.7M -$3.95M +$495K +11.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$20.2M -$4.57M -$10.4K -0.23% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$20.2M -$5.39M +$24K +0.44% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$20.2M -$5.82M -$2.33M -66.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$17.9M -$4.45M +$561K +11.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$18.5M -$4.56M -$1.36M -42.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$17.1M -$5.41M -$1.6M -42% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$15.5M -$3.49M -$2.14M -158% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$13.4M -$5.01M +$902K +15.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$14.3M -$3.2M -$54.4K -1.73% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$14.2M -$3.81M -$2.07M -118% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$12.2M -$1.35M -$1.28M -1669% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$10.9M -$5.91M -$3.29M -126% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$7.59M -$3.14M -$2.85M -987% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$4.73M -$1.74M -$655K -60.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
Q4 2012 -$4.08M -$76.6K +$2.28M +96.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 -$6.35M -$2.62M -$1.49M -132% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-19
Q2 2012 -$4.86M -$289K +$1.11M +79.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-19
Q1 2012 -$5.96M -$1.09M +$428K +28.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-19
Q4 2011 -$6.39M -$2.35M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$1.13M -$224K -24.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-04-01
Q2 2011 -$1.39M -$65.6K -4.94% Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 -$1.52M Jan 1, 2011 Mar 31, 2011 10-K 2013-04-01
Q3 2010 -$904K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.33M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.